Skip to main content

Reproducibility and research integrity

Inquiry

As the UK seeks to recover from the pandemic, research and innovation has the ability to drive economic growth, with UKRI estimating that every £1 spent on research and development delivers £7 in economic and social benefit. However, the integrity of research, especially medical and social science research, is at risk from what is known as the ‘reproducibility crisis’ (i.e. it being very difficult or impossible to replicate a scientific study).

As early as 2005, the issue of reproducibility was identified in Ioannidis’ paper, ‘Why Most Published Research Findings Are False,’ and since then a large number of surveys or replication studies have been conducted that show the prominence of the issue.

So far, Government policy has focused on the overall theme of ‘Research Integrity,’ including asking UKRI to establish a national research integrity committee as recommended by our predecessor Committee, but the specific issue of reproducible research has been overlooked.

This inquiry is no longer accepting evidence

The deadline for submissions was Thursday 30 September 2021.

Reports, special reports and government responses

No reports or special reports published.

Oral evidence transcripts

View all oral evidence transcripts
2 February 2022
Inquiry Reproducibility and research integrity
Witnesses Professor Dame Ottoline Leyser (Chief Executive at UK Research and Innovation (UKRI)), James Parry (Chief Executive at UK Research Integrity Office), and George Freeman (Minister for Science, Research and Innovation at Department for Business, Energy and Industrial Strategy)
Committees Science and Technology Committee
Oral Evidence
19 January 2022
Inquiry Reproducibility and research integrity
Witnesses Professor Sebastian Vollmer (Professor for Application of Machine Learning at TU Kaiserslautern)
Committees Science and Technology Committee
Oral Evidence
15 December 2021
Inquiry Reproducibility and research integrity
Witnesses Dr Ben Goldacre (Director at Nuffield Department of Primary Care Health Sciences, University of Oxford), Dr Jessica Butler (Analytical Lead and Research Fellow at University of Aberdeen), Springer Nature, Dr Elizabeth Moylan (Publisher, Research Integrity and Publishing Ethics at Wiley), The Lancet, Viscount Ridley (Co-author at Viral: The Search for the Origin of Covid-19), and Dr Alina Chan (Co-author at Viral: The Search for the Origin of Covid-19)
Committees Science and Technology Committee
Oral Evidence
RRE0104 - Reproducibility and research integrity
Witnesses UK Committee on Research Integrity
Committees Science and Technology Committee
Written Evidence
RRE0103 - Reproducibility and research integrity
Witnesses UK Research and Innovation (UKRI)
Committees Science and Technology Committee
Written Evidence
RRE0102 - Reproducibility and research integrity
Witnesses Department for Business, Energy and Industrial Strategy
Committees Science and Technology Committee
Written Evidence

Contact us

We can’t usually help you with an individual problem or a specific complaint.

  • Email: scitechcom@parliament.uk
  • Phone: 020 7219 2793 (General enquiries) / 020 7219 3172 (Media enquiries) / 18001 20 7219 2793 (text relay)
  • Address: Science and Technology Committee, House of Commons, London, SW1A 0AA